Selective regulation of MAPK signaling mediates RANKL-dependent osteoclast differentiation

International Journal of Biological Sciences

Volumn 12, Issue 2, 2016, Pages 235-245

  Lee, Kyunghee ^a   Chung, Yeoun Ho ^a   Ahn, Heejin ^a   Kim, Hyunsoo ^a   Rho, Jaerang ^b   Jeong, Daewon ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

M CSF; MAPK signaling; Osteoclast differentiation; RANKL

Indexed keywords

COLONY STIMULATING FACTOR 1; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; OSTEOCLAST; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN ISOFORMS; RANK LIGAND; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84956905638     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.13814     Document Type: Article

References (45)

1. Krishna M, Narang H. The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci. 2008; 65: 3525-44.
2. Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta. 2007; 1773: 1161-76.
3. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298: 1911-2.
4. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004; 68: 320-44.
5. Chen JY, Lin JR, Cimprich KA, Meyer T. A two-dimensional ERK-AKT signaling code for an NGF-triggered cell-fate decision. Mol Cell. 2012; 45: 196-209.
6. Vaudry D, Stork PJ, Lazarovici P, Eiden LE. Signaling pathways for PC12 cell differentiation: making the right connections. Science. 2002; 296: 1648-9.
7. Qui MS, Green SH. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron. 1992; 9: 705-17.
8. York RD, Molliver DC, Grewal SS, Stenberg PE, McCleskey EW, Stork PJ. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol Cell Biol. 2000; 20: 8069-83.
9. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80: 179-85.
10. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 2007; 134: 2895-902.
11. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. The Journal of biological chemistry. 2000; 275: 9645-52.
12. Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007; 13: 791-801.
13. Blair HC, Robinson LJ, Zaidi M. Osteoclast signalling pathways. Biochem Biophys Res Commun. 2005; 328: 728-38.
14. Negishi-Koga T, Takayanagi H. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev. 2009; 231: 241-56.
15. Ross FP. M-CSF, c-Fms, and signaling in osteoclasts and their precursors. Ann N Y Acad Sci. 2006; 1068: 110-6.
16. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006; 12: 17-25.
17. Sankar U, Patel K, Rosol TJ, Ostrowski MC. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J Bone Miner Res. 2004; 19: 1339-48.
18. Mizoguchi T, Muto A, Udagawa N, Arai A, Yamashita T, Hosoya A, et al. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol. 2009; 184: 541-54.
19. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, et al. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. The Journal of biological chemistry. 2002; 277: 47366-72.
20. Novack DV, Teitelbaum SL. The osteoclast: friend or foe? Annu Rev Pathol. 2008; 3: 457-84.
21. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003; 423: 337-42.
22. Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D, Dougall WC. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. The Journal of biological chemistry. 2002; 277: 44347-56.
23. Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 2001; 20: 1271-80.
24. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell. 1999; 4: 1041-9.
25. Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie. 2006; 88: 1091-8.
26. Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. The Journal of experimental medicine. 2005; 202: 589-95.
27. Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, et al. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. The Journal of biological chemistry. 2003; 278: 44975-87.
28. Huang H, Ryu J, Ha J, Chang EJ, Kim HJ, Kim HM, et al. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. Cell death and differentiation. 2006; 13: 1879-91.
29. Friedman A, Perrimon N. Genetic screening for signal transduction in the era of network biology. Cell. 2007; 128: 225-31.
30. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science. 2002; 298: 1241-5.
31. von Kriegsheim A, Baiocchi D, Birtwistle M, Sumpton D, Bienvenut W, Morrice N, et al. Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol. 2009; 11: 1458-64.
32. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 1985; 41: 665-76.
33. Jacquel A, Benikhlef N, Paggetti J, Lalaoui N, Guery L, Dufour EK, et al. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages. Blood. 2009; 114: 3633-41.
34. Huynh J, Kwa MQ, Cook AD, Hamilton JA, Scholz GM. CSF-1 receptor signalling from endosomes mediates the sustained activation of Erk1/2 and Akt in macrophages. Cell Signal. 2012; 24: 1753-61.
35. Hamilton JA. CSF-1 signal transduction. J Leukoc Biol. 1997; 62: 145-55.
36. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 2004; 14: 628-38.
37. Nakashima T, Takayanagi H. Osteoclasts and the immune system. J Bone Miner Metab. 2009; 27: 519-29.
38. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103: 239-52.
39. Liu J, Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell research. 2005; 15: 36-42.
40. Agell N, Bachs O, Rocamora N, Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell Signal. 2002; 14: 649-54.
41. Lee PS, Wang Y, Dominguez MG, Yeung YG, Murphy MA, Bowtell DD, et al. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 1999; 18: 3616-28.
42. Wang Y, Yeung YG, Stanley ER. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J Cell Biochem. 1999; 72: 119-34.
43. Manger R, Najita L, Nichols EJ, Hakomori S, Rohrschneider L. Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms). Cell. 1984; 39: 327-37.
44. Guilbert LJ, Stanley ER. The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. The Journal of biological chemistry. 1986; 261: 4024-32.
45. Yoshizawa T, Hammaker D, Boyle DL, Corr M, Flavell R, Davis R, et al. Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression. J Immunol. 2009; 183: 1360-7.